Inicio › Dermatitis atópica (eccema) › Florida

Ensayos clínicos de Dermatitis atópica (eccema) en Florida

19 estudios sobre Dermatitis atópica (eccema) buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Pediatric Skin Research, Miami
AllerVie Clinical Research, Panama City
GCP Research , Global Clinical Professionals, St. Petersburg

ReclutandoFase 3

Edades de 12 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07765888

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

True Blue Clinical Research, Tampa

ReclutandoEstudio observacional

Edades de 12 a 89 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07645820

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Leo Pharma Investigational site, Jacksonville
Leo Pharma Investigational site, Miami
Leo Pharma Investigational site, Tampa

ReclutandoFase 3

6 Months – 11 Years · Todos los sexos · Actualizado el 9 nov 2026 · NCT06311682

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

Florida International Research Center, Miami
Encore Medical Research of Weston LLC, Weston

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 65 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07527923

Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis

Arcutis Site 321, Miami Lakes

ReclutandoFase 3

Edades de 6 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07916480

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

Direct Helpers Research Center, Hialeah
Research Associates of South Florida, LLC, Miami
Global Health Research Center, Inc., Miami Lakes
y 2 más

ReclutandoFase 3

Edades de 12 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07783425

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Solutions Through Advanced Research, Jacksonville

ReclutandoFase 3

Edades de 2 a 11 · Todos los sexos · Actualizado el 5 nov 2026 · NCT06807281

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Miami Dermatology and Laser Research, Miami

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 70 · Todos los sexos · Actualizado el 5 nov 2026 · NCT06564389

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Gsi Clinical Research, Margate

ReclutandoFase 2

Edades de 18 a 64 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Coral Gables
Investigational Site, Jacksonville
Investigational Site, Margate

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07003425

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

St. Jude Clinical Research- Site Number : 8400049, Doral
Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07290803

A Study Evaluating TRIV-573 in Atopic Dermatitis

Triveni Bio Site #11, Boca Raton
Triveni Bio Site #7, Miami
Triveni Bio Site #3, Miami

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07782333

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Clinical Site 112, Miami
Clinical Site 110, Miami

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 65 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07453602

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Miami
Novartis Investigative Site, St. Petersburg

ReclutandoFase 2

Edades de 18 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Fort Lauderdale
Enveda Investigative Site, Miami
Enveda Investigative Site, Miramar

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07298395

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

ABMED Clinical Research Corp., Cape Coral
Skin Care Research, Hollywood
Quality Care Clinical Research, Miami
y 4 más

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 28 ago 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 19, Ocala
Inmagene Site 4, Tampa

ReclutandoFase 2

Edades de 18 a 74 · Todos los sexos · Actualizado el 12 ago 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Boca Raton

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT07643766

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site 8597, Boca Raton
Galderma Investigational Site 7087, Coral Gables
Galderma Investigational Site 7063, Cutler Bay
y 7 más

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT06988605

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.